黑料社

PH cancer patients lack access to preventive screening, costly treatment

PH cancer patients lack access to preventive screening, costly treatment

COMPOSITE IMAGE: DANIELLA MARIE AGACER FROM INQ STOCK PHOTOS

MANILA, Philippines鈥擥lobal advances and innovations in the medical field have already made cancer treatable and preventable. However, Filipino cancer patients still miss preventive screenings, while many bear the enormous costs of cancer illness.

Estimates by the Global Cancer Observatory (Globocan) showed that 153,751 Filipinos suffer from various types of cancer as of 2020. Among these were 27,163 breast cancer patients, 19,180 lung cancer patients, and 17,364 colorectum cancer patients.

GRAPHIC COURTESY OF Valerie Ulep, senior research fellow at the Philippine Institute for Development Studies (PIDS)

However, medical advances have made cancer preventable and treatable, helping many cancer patients recover and win their battle against the 鈥淏ig C.鈥

搁贰础顿:听Targeted therapy makes waves as brightest hope for cancer treatment

鈥淲e can beat cancer now. We can save lives. And we are trying our best to make treatment accessible nationwide, especially to those who cannot afford the treatment,鈥 Dr. Marvin Mendoza, head of the oncology section at the聽National Kidney and Transplant Institute (NKTI), previously said.

Cancer: Preventable,聽but鈥

Several public health mechanisms supporting cancer control services are being implemented. Among these are the early screening and detection procedures currently offered for patients in the Philippines.

鈥淎 big portion [of the] country鈥檚 cancer burden is preventable. However, it boils down to comprehensive preventative and curative interventions for the population,鈥 said Valerie Ulep, a senior research fellow at the Philippine Institute for Development Studies (PIDS).

However, in his study, Ulep found that many Filipino women still do not have access to preventive screening for breast cancer鈥攖he leading type of cancer among Filipino women of all ages鈥攁nd cervical cancer鈥攖he second most common cancer among women in the Philippines.

GRAPHIC Ed Lustan

鈥淏reast and cervical cancer screening are extremely low in the Philippines compared to upper-middle and high-income countries,鈥 Ulep explained.

鈥淸I]n countries like Malaysia, the prevalence of self-breast examination among women (40 years old and above) is almost 50%, mammogram use is 20%, and PAP smear is about 40%. High-income (OECD) countries even have higher rates than Malaysia,鈥 he added.

A separate聽study聽published last year attributed low breast and cervical cancer screening among Filipino women to low health literacy and gender sociocultural pressures.

A聽health system review聽conducted under the Asia Pacific Observatory on Health Systems and Policies (the APO) and published by the World Health Organization (WHO) noted that among the multiple barriers causing low cancer screening are low health literacy, high out-of-pocket (OOP) health care costs, and the centralization of health care infrastructure and providers.

Patient bear costs of cancer

Cancer treatment involves radiation therapy, immunotherapy, targeted therapy, and chemotherapy. The last, according to the US-based Mayo Clinic, is the most often used treatment method.

In the Philippines, the cost of cancer treatment can range from聽鈧120,000 to as much as over聽鈧1 million. The estimated price of chemotherapy cost per session, depending on the cancer type, meanwhile starts at聽鈧20,000 up to over聽鈧120,000.

While efforts have been made to make cancer treatment鈥攊ncluding chemotherapy, targeted therapy, and chemotherapy drugs鈥攁vailable and accessible to more Filipino cancer patients, many still rely on their own hard-earned money to pay for the medical services they needed.

GRAPHIC Ed Lustan

Citing data from the Cost of Illness of Cancer survey, Ulep bared that among cancer patients who receive inpatient medical services in public hospitals, around 15 percent of the cost of medical care is still paid out-of-pocket.

Over half鈥55 percent鈥攐f the inpatient medical bill is covered by PhilHealth, while the remaining balance is paid by private entities (9 percent), local government units or the health department (7 percent), and other sources (14 percent).

On the other hand, out-of-pocket expenses for inpatient spending in private hospitals were much higher (41 percent). PhilHealth covers 46 percent of the costs of medical services among these patients.

According to Ulep, 92 percent of the inpatient spending goes to hospital bills, 6 percent is for non-medical bills (including transportation), and 3 percent covers the cancer drug purchased outside during admission.

搁贰础顿:听Long lines, lengthy treatment wear out PH cancer patients

Data also showed that out-of-pocket and other forms聽of private spending account for the majority of outpatient visits.

GRAPHIC Ed Lustan

Outpatient spending in public hospitals is settled through out-of-pocket (29 percent), PhilHealth (24 percent), religious/other organizations (27 percent), and donations (20 percent).

Cancer patients receiving outpatient medical care from private hospitals meanwhile pay 65 percent of their bill. Other sources such as religious/other organizations, PhilHealth, private insurance, and donation covers 19 percent, 8 percent, 5 percent, and 3 percent, respectively.

鈥淭he main source of outpatient spending are OOP, which are regressive and catastrophic,鈥 said Ulep.

鈥淲hile PhilHealth provides a significant financial protection during admissions episodes, households remain at risk of exposure to catastrophic spending because the SV of PhilHealth is only 50% excluding the purchases outside hospitals,鈥 he added.

鈥楩inancial toxicity鈥 burdens patients, families

A study published in 2018 in Acta Medica Philippina鈥攁 peer-reviewed general medical and health science journal published by the University of the Philippines (UP)鈥攈ighlighted the economic impact of cancer diagnosis in families.

The study, which analyzed 909 cancer patients in the Philippines, found that 40.6 percent of cancer patients鈥 families experienced financial toxicity鈥攐r financial problems鈥攄ue to the high cost of medical care.

GRAPHIC Ed Lustan

The researchers also found that the mean combined out-of-pocket expenses of respondents at 3 and 12 months after diagnosis amounted to聽鈧181,789.00.

搁贰础顿:听鈥楩inancial toxicity鈥 hurting PH cancer patients

Previously published statistics also showed that at least 7 in 10 cancer patients in the country 鈥渄rop out of treatment regimen鈥 due to lack of funds.

In a statement last February 9, the NKTI announced that 23 public hospitals have started聽offering free targeted therapies for breast cancer patients who cannot afford the required 18 treatment cycles, which cost from 鈧300,000 to 鈧450,000.

鈥淥ptions for treatment include a subcutaneous injection that takes about 5 minutes to administer or a three-hour intravenous administration that also requires an additional two hours or so for preparation,鈥 said Dr. Mendoza.

However, only 200 patients will be accommodated nationwide for the free cancer treatment due to the limited budget for the treatment program.

搁贰础顿:听More funding, assistance bring cancer patients closer to recovery

More funds sought

To help boost cancer screening in the country,聽 advocates like Cancer Coalition and Citizen鈥檚 Watch are pressing Congress to increase its roughly聽鈧1-billion annual budget for the anti-cancer program of the Department of Health (DOH).

Last month,聽Congress restored the government funds for cancer鈥攆rom being excluded in the 2023 General Appropriations Act (GAA)鈥攖o a total of聽鈧1.56 billion.

In a statement last February 5, Deputy Speaker and Batangas Rep. Ralph Recto said the line-item funding for two cancer funds in this year鈥檚 national budget was a 鈥渞esult of a multi-partisan, bicameral push.鈥

GRAPHIC Ed Lustan

鈥淸R]estoring the cancer fund in the national budget is one doctor鈥檚 order we cannot ignore. The cancer fund is not a tumor that must be excised from the budget. It is a treatment tool which, on the contrary, must be boosted,鈥 said Recto.

Of the聽鈧1.56 billion that will be lodged under DOH, P1.054 billion will subsidize cancer prevention, detection, treatment, and care, in line with Republic Act No. 11215 or the National Integrated Cancer Control Act鈥攚hich aims to prevent cancer and improve cancer survivorship, and make cancer treatment and care more equitable and affordable for all.

The lawmaker said the fund will specifically finance the 鈥減rocurement and delivery of cancer, supportive care and palliative care medicines covering the eight treatable cancer types.鈥

The remaining聽鈧500 million will go to the Cancer Assistance Fund (CAF), which will be used for cancer prevention, detection, treatment, diagnostics, and care for the eight priority cancer types identified by the DOH.

GRAPHIC Ed Lustan

On top of the restored cancer funds, a joint memorandum circular outlining the guidelines for using the CAF released last year stated that聽鈧529.2 million worth of funds for cancer patients will remain valid until the end of 2023.

搁贰础顿:听Cancer assistance fund of P529.2M available until end of 2023 鈥 DBM

鈥淲e can beat cancer. We can save lives. We can do more if the budget is increased by Congress,鈥 Mendoza previously said.

搁贰础顿:听Bigger cancer budget equals better treatment, fewer deaths in PH

TSB

Read more...